
Flect'Expert Harpagophytum Patch Instant warm effect x5
Indications :
Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.
IMPORTANT! New orders to the United States are temporarily suspended.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Each box contains 1 x 2 ml pre-filled syringe (32 mg (H-HA) + 32 mg (L-HA) sodium hyaluronate in 2 ml buffered physiological sodium chloride solution) and a 21 G x 1½ " (0.8 x 40 mm) needle.
Sinovial HL is used in the treatment of osteoarthritis and is particularly indicated in cases of pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations. As a synovial fluid replacement agent, it helps restore the physiological and rheological properties of arthritic joints. Sinovial HL naturally restores the viscoelastic properties of synovial fluid, rapidly reducing pain and restoring mobility to joints and tendons. It acts only at the level of the joint into which it is injected, and has no systemic action.
A maximum of three injections may be given, depending on the severity of the joint degeneration. It is the doctor's responsibility to assess the appropriateness of repeating the treatment and its frequency for each patient, taking into account the benefit/risk ratio of the treatment in each case.
Aspirate any joint effusion before injecting Sinovial HL.
Carefully unscrew the cap on the end of the syringe, holding the Luer-Lock connector firmly with your fingers and taking care to avoid contact with the opening.
While holding the syringe's Luer-Lock connector firmly, attach the 21 G needle (contained in the pack) by rotating it until a slight counter-pressure is felt, to ensure a tight connection and prevent any liquid leaking out during administration.
Inject only into the synovial space, at room temperature and under strict aseptic conditions.
Intra-articular injection must only be performed by a doctor.
The contents of the pre-filled syringe are sterile. The syringe and needle are supplied in a sealed blister pack.
The outer surface of the syringe is not sterile.
Do not use the device beyond the expiry date indicated on the packaging.
Do not use the device if the packaging is open or damaged.
The skin at the injection site must be healthy.
Do not inject intravenously. Do not inject outside the joint cavity, into synovial tissue or into the joint capsule.
Do not administer Sinovial HL in the event of severe intra-articular effusion.
Do not resterilize. The device is designed for single use only.
Do not reuse to avoid contamination.
Keep out of sight and reach of children.
After intra-articular injection, patients should avoid strenuous physical activity and wait a few days before resuming normal activity.
The presence of an air bubble in no way affects the quality of the product.
Do not use at the same time as disinfectants containing quaternary ammonium salts or chlorhexidine to prepare the skin, as precipitation of hyaluronic acid is possible in their presence.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative
diseases (arthrosis), post-traumatic diseases or tendinopathy linked to
joint alterations. Read instructions carefully before use. Class III medical device. CE mark
0373. Manufacturer: IBSA Farmaceutici Italia. Not covered by LPPR
Date of publication or document update : June - 2019
Leaflet available here: https: //lagammevisco.fr/produit/sinovial-hl/
Sinovial® HL should not be injected into infected or severely inflamed joints, or into patients with skin disorders or infections at the injection site
Extra-articular infiltration of Sinovial HL may cause local adverse effects. When using Sinovial HL, symptoms such as pain, warmth, redness or swelling may appear at the injection site. Applying ice to the treated joint may help relieve these side effects. They generally disappear rapidly. Physicians should ask patients to inform them of any adverse effects occurring after treatment.
No known interactions to date.
Based on the results of in vitro studies to date, there is no biological or chemico-physical interaction between Sinovial HL and platelet-rich plasma (PRP) injections used as infiltration for the treatment of osteoarthritis.
Storage conditions
Store between 0 and 25°C, away from sources of heat. Do not freeze.
Once opened, use immediately and discard after use.
Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Ostenil Plus is a transparent solution of natural and highly purified hyaluronic acid, obtained by bacterial fermentation and free of animal proteins. Ostenil Plus also contains mannitol, a free radical scavenger, which helps stabilize the hyaluronic acid chains. Biocompatibility studies have shown that Ostenil Plus is well tolerated.
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
This medicine is used as a ground modifier especially during infectious and viral conditions, flu-like conditions, inflammatory rheumatic conditions and during arthrosis.
Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.
The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.
Intra-articular injection of hyaluronic acid forarthropathy causing pain or limited mobility. This medical device is a regulated healthcare product, and carries the CE mark.
- Restore the viscoelastic properties of synovial fluid
- Reduce pain
- Improve joint mobility
Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.
Pain relief improves joint function and helps restore quality of life.
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
Pain-relieving gel, based on essential oils, provides rapid pain relief, limits the spread of oedema and promotes relaxation. Pain-relieving gel for contractures, strains, sprains, contusions, elongations, strains, post-traumatic conditions, arthrosis and arthritis.
It rapidly relieves pain, limits the spread of oedema and promotes muscle relaxation and recovery.
Indication: Muscle and joint pain relief. From age 7.
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.